Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr 26:9:2447-53.
doi: 10.2147/OTT.S98577. eCollection 2016.

E-cadherin expression and prognosis of head and neck squamous cell carcinoma: evidence from 19 published investigations

Affiliations

E-cadherin expression and prognosis of head and neck squamous cell carcinoma: evidence from 19 published investigations

Xusheng Ren et al. Onco Targets Ther. .

Abstract

Objective: The objective of this study was to review the published literature and investigate whether E-cadherin gene is a prognostic factor in head and neck squamous cell carcinoma by conducting a meta-analysis.

Methods: Studies were identified from the databases Embase, Medline, and Cochrane Library by using the keywords "E-cadherin gene" and "head and neck cancer". Overall survival (OS) and disease-free survival (DFS) were the primary outcome measurements.

Results: Our literature review identified 1,458 articles; 19 studies with a total number of 2,012 cases were eligible for inclusion in the meta-analysis. The hazard ratio (HR) for OS of patients with decreased expression of E-cadherin gene was 0.57 (95% CI =0.37, 0.89; P=0.000). However, statistical heterogeneity was unacceptably high (I (2)=74.5%, P=0.000). After sensitivity analysis, heterogeneity became acceptable, and the effect measure was still significant (I (2)=7.0%; HR =0.52; 95% CI =0.40, 0.66; P=0.000). The HR for DFS was 0.53 (95% CI =0.42, 0.67; P=0.000).

Conclusion: This meta-analysis showed clear evidence that high E-cadherin gene expression is a positive prognostic factor of head and neck squamous cell carcinoma, resulting in better OS and DFS. However, this conclusion must be interpreted with caution due to a few limitations.

Keywords: E-cadherin gene; head and neck squamous cell carcinoma; immunohistochemistry; prognosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A flow diagram of literature search.
Figure 2
Figure 2
A forest plot for overall survival. Notes: The difference between the two groups was significant (HR =0.57; 95% CI =0.37, 0.89; P=0.000). However, there was great statistical heterogeneity (I2=74.5%, P=0.000). After sensitivity analysis, heterogeneity became acceptable (I2=7.0%) and the effect measure remained significant (HR =0.52; 95% CI =0.40, 0.66; P=0.000). “1” means after sensitivity analysis and “1+2” means before sensitivity analysis. Weights are from random effects analysis. Abbreviations: HR, hazard ratio; CI, confidence interval.
Figure 3
Figure 3
A forest plot for overall survival. Note: The difference between the high E-cadherin group and the low E-cadherin group was significant (HR =0.53; 95% CI =0.42, 0.67; P=0.000) and the heterogeneity was acceptable (I2=0.0%, P=0.860). Abbreviations: HR, hazard ratio; CI, confidence interval.
Figure 4
Figure 4
A funnel plot of meta-analysis of overall survival. Note: According to the funnel plot, there is an asymmetry. Abbreviations: HR, hazard ratio; SE, standard error; CI, confidence interval.
Figure 5
Figure 5
A funnel plot of meta-analysis of disease-free survival. Note: According to the funnel plot, there is an asymmetry. Abbreviations: HR, hazard ratio; SE, standard error; CI, confidence interval.

Similar articles

Cited by

References

    1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
    1. Ren ZH, Xu JL, Fan TF, Ji T, Wu HJ, Zhang CP. The harmonic scalpel versus conventional hemostasis for neck dissection: a meta-analysis of the randomized controlled trials. PLoS One. 2015;10:e0132476. - PMC - PubMed
    1. Silverman S., Jr Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc. 2001;132(suppl):7S–11S. - PubMed
    1. Chandler K, Vance C, Budnick S, Muller S. Muscle invasion in oral tongue squamous cell carcinoma as a predictor of nodal status and local recurrence: just as effective as depth of invasion? Head Neck Pathol. 2011;5:359–363. - PMC - PubMed
    1. Ren ZH, Wu HJ, Zhang S, et al. A new surgical strategy for treatment of tongue squamous cell carcinoma based on anatomic study with preliminary clinical evaluation. J Craniomaxillofac Surg. 2015;43:1577–1582. - PubMed

LinkOut - more resources